First up.

This Taiwanese cancer registry reveals that, even for breast cancer with >50% expression of ER, the risk of death was 2.7x higher among women who received endocrine therapy (n=145) versus chemotherapy (n=495) in the neoadjuvant setting. | Zhang, JAMA Netw Open 2021

Comments

Popular Posts